A new fibrin sealant as a three-dimensional scaffold candidate for mesenchymal stem cells

Stem Cell Research and Therapy

Volumn 5, Issue 3, 2014, Pages

  Gasparotto, Vinícius P O ^a   Landim Alvarenga, Fernanda C ^a   Oliveira, Alexandre L R ^a,b   Simões, Gustavo Ferreira ^b   Lima Neto, João F ^a   Barraviera, Benedito ^a   Ferreira, Rui S ^a  

^a SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

^b UNIVERSITY OF CAMPINAS   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

BIOMATERIAL; CD34 ANTIGEN; FIBRIN GLUE; HERMES ANTIGEN; HOE 33342; PROPIDIUM IODIDE; SNAKE VENOM; THY 1 ANTIGEN;

ADIPOGENESIS; ANIMAL CELL; ANTIGEN EXPRESSION; ARTICLE; BLOOD; BONE DEVELOPMENT; CELL ADHESION; CELL DIFFERENTIATION; CELL FUNCTION; CELL GROWTH; CELL LINEAGE; CELL PROLIFERATION; CELL SURFACE; CELL SURVIVAL; CELL VIABILITY; CHONDROGENESIS; CONTROLLED STUDY; COST BENEFIT ANALYSIS; DRUG DELIVERY SYSTEM; ELECTRON MICROSCOPY; FLOW CYTOMETRY; IN VITRO STUDY; MESENCHYMAL STEM CELL; MICROENVIRONMENT; NONHUMAN; PRIORITY JOURNAL; RAT; ANIMAL; CHEMISTRY; CYTOLOGY; MESENCHYMAL STROMA CELL; PHYSIOLOGY; PROCEDURES; TISSUE ENGINEERING; TISSUE SCAFFOLD; WISTAR RAT;

ANIMALS; CELL ADHESION; CELL DIFFERENTIATION; CELL PROLIFERATION; FIBRIN TISSUE ADHESIVE; FLOW CYTOMETRY; MESENCHYMAL STROMAL CELLS; RATS; RATS, WISTAR; SNAKE VENOMS; TISSUE ENGINEERING; TISSUE SCAFFOLDS;

EID: 84903985284     PISSN: None     EISSN: 17576512     Source Type: Journal    
DOI: 10.1186/scrt467     Document Type: Article

References (31)

1. Fibrin glues in combination with mesenchymal stem cells to develop a tissue-engineered cartilage substitute. Ahmed TAE, Giulivi A, Griffith M, Hincke M, Tissue Eng 2011 17 323
2. Characterization and inhibition of fibrin hydrogel degrading enzymes during development of tissue engineering scaffolds. Ahmed TA, Griffith M, Hincke M, Tissue Eng 2007 13 1469
3. Fibrin: a versatile scaffold for tissue engineering applications. Ahmed TA, Dare EV, Hincke M, Tissue Eng 2008 14 199
4. Genipin cross-linked fibrin hydrogels for in vitro human articular cartilage tissue-engineered regeneration. Dare EV, Griffith M, Poitras P, Kaupp JA, Waldman SD, Carlsson DJ, Dervin G, Mayoux C, Hincke MT, Cells Tissues Organs 2009 190 313
5. Caplan AI, Principles of Regenerative Medicine Burlington, MA: Elsevier 2 2011
6. Gene expression profiling of human mesenchymal stem cells derived from bone marrow during expansion and osteoblast differentiation. Kulterer B, Friedl G, Jandrositz A, Sanchez-Cabo F, Prokesch A, Paar C, BMC Genomics 2007 8 70
7. In vitro neuronal and osteogenic differentiation of mesenchymal stem cells from human umbilical cord blood. Park KS, Lee YS, Kang KS, J Vet Sci 2006 7 343 348
8. Mesenchymal stem cell-based therapies in regenerative medicine: applications in rheumatology. Maumus M, Guérit D, Toupet K, Jorgensen C, Noël D, Stem Cell Res Ther 2011 2 14
9. Regulation of proliferation and chondrogenic differentiation of human mesenchymal stem cells by laminin-5 (laminin-332). Hashimoto J, Kariya Y, Miyazaki K, Stem Cells 2006 24 2346 2354 (Pubitemid 44674293)
10. A real-time PCR approach to evaluate adipogenic potential of amniotic fluid-derived human mesenchymal stem cells. De Gemmis P, Lapucci C, Bertelli M, Tognetto A, Fanin E, Vettor R, Stem Cells Dev 2006 15 719 728 (Pubitemid 44748607)
11. Cardiac repair with intramyocardial injection of allogeneic mesenchymal stem cells after myocardial infarction. Amado LC, Saliaris AP, Schuleri KH, St John M, Xie JS, Cattaneo S, Proc Natl Acad Sci U S A 2005 102 11474 11479 (Pubitemid 41153844)
12. Encapsulation and 3D culture of human adipose-derived stem cells in an in-situ crosslinked hybrid hydrogel composed of PEG-based hyperbranched copolymer and hyaluronic acid. Hassan W, Dong Y, Wang W, Stem Cell Res Ther 2013 4 32
13. Smart materials as scaffolds for tissue engineering [review]. Rosso F, Marino G, Giordano A, Barbarisi M, Parmeggiani D, Barbarisi A, J Cell Physiol 2005 203 465
14. Human mesenchymal stem cell proliferation and osteogenic differentiation in fibrin gels in vitro. Catelas I, Sese N, Wu BM, Dunn JCY, Helgerson S, Tawil B, Tissue Eng 2006 12 2385
15. Surgical adhesives. Thomazini-Santos IA, Barraviera SRCS, Mendes-Giannini MJS, Barraviera B, J Venom Anim Toxins 2001 7 159
16. A new fibrin sealant from Crotalus durissus terrificus venom: applications in medicine. Barros LC, Ferreira RS Jr, Barraviera SRCS, Stolf HO, Thomazini-Santos IA, Mendes-Giannini MJS, Toscano E, Barraviera B, J Toxicol Env Health B 2009 12 553 571
17. Biochemical and biological evaluation of gyroxin isolated from Crotalus durissus terrificus venom. Barros LC, Soares AM, Costa FL, Rodrigues VM, Fuly AL, Giglio JR, Gallacci M, Thomazini-Santos IA, Barraviera SRCS, Barraviera B Jr, Ferreira RS, J Venom Anim Toxins 2011 17 23
18. Fibrin sealants produced by the CryoSeal® FS system: product chemistry, material properties and possible preparation in the autologous preoperative setting. Buchta C, Dettke M, Funovics PT, Hocker P, Knobl P, Macher M, Quehenberger P, Treitl C, Worel N, Vox Sang 2004 86 257
19. Systematic review of the use of fibrin sealant to minimize perioperative allogeneic blood transfusion. Carless PA, Anthony DM, Henry DA, Br J Surg 2002 89 695
20. A biodegradable fibrin scaffold for mesenchymal stem cell transplantation. Bensaid W, Triffitt JT, Blanchat C, Oudina K, Sedel L, Petite H, Biomaterials 2003 24 2497
21. The use of fibrin adhesive derived from snake venom and the evaluation of skin grafting using skin from the patient's nasolabial fold. Stolf HO, J Venom Anim Toxins 1999 5 227
22. Viability and cell cycle analysis of equine fibroblasts cultured in vitro. Lima-Neto JF, Fernandes CB, Alvarenga MA, Golim MA, Landim-Alvarenga FC, Cell Tissue Bank 2010 11 261
23. Diferenciação in vitro de células-tronco mesenquimais da medula óssea de cães em precursores osteogênicos [In vitro differentiation of mesenchymal stem cells of dogs into osteogenic precursors]. Lima SAF, Wodewotzky TI, Lima-Neto JF, Beltrão-Braga PCB, Landim-Alvarenga FC, Pesquisa Vet Brasil 2012 32 463
24. Biological characteristics of mesenchymal stem cells. Bydlowski SP, Debes AA, Maselli LMF, Janz FL, Rev Bras Hematol Hemoter 2009 31 25 35
25. Derivation of neural stem cells from mesenchymal stem cells: evidence for a bipotential stem cell population. Fu L, Zhu L, Huang Y, Lee TD, Forman SJ, Shih CC, Stem Cells Dev 2008 17 1109 1122
26. Differential expression pattern of extracellular matrix molecules during chondrogenesis of mesenchymal stem cells from bone marrow and adipose tissue. Mehlhorn AT, Niemeyer P, Kaiser S, Finkenzeller G, Stark GB, Sudkamp NP, Schmal H, Tissue Eng 2006 12 2853
27. Hyaluronan and fibrin biomaterial as scaffolds for neuronal differentiation of adult stem cells derived from adipose tissue and skin. Gardin C, Vindigni V, Bressan E, Ferroni L, Nalesso E, Puppa AD, D'Avella D, Lops D, Pinton P, Zavan B, Int J Mol Sci 2011 12 6749 6764
28. Regenerative potential of human periodontal ligament derived stem cells on three-dimensional biomaterials: a morphological report. Trubiani O, Orsini G, Zini N, Di Iorio D, Piccirilli M, Piattelli A, J Biomed Mater Res 2008 87 986 993
29. Bone regeneration following injection of mesenchymal stem cells and fibrin glue with a biodegradable scaffold. Yamada Y, Boo JS, Ozawa R, Nagasaka T, Okazaki Y, Hata K, Ueda M, J Cranio Maxill Surg 2003 31 27 33 (Pubitemid 36240677)
30. A success in toxinology translational research in Brazil: bridging the gap. Ferreira ASBS, Barraviera B, Barraviera SRCS, Abbade LPF, Caramori CA, Ferreira RS, Toxicon 2013 69 50 54
31. Motor recovery and synaptic preservation after ventral root avulsion and repair with a fibrin sealant derived from snake venom. Barbizan R, Castro MV, Rodrigues AC, Barraviera B, Ferreira RS, Oliveira ALR, Plos One 2013 8 63260 Pessoal de Nível Superior Aperfeiçoamento de Pessoal de Nível Superior